Macrophage adaptation in airway inflammatory resolution

European Respiratory Review

Volumn 24, Issue 137, 2015, Pages 510-515

  Kaur, Manminder ^a   Bell, Thomas ^a   Salek Ardakani, Samira ^a   Hussell, Tracy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; AUTACOID;

APOPTOSIS; ARTICLE; ASTHMA; BACTERIAL INFECTION; CELL POPULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MICROENVIRONMENT; MORBIDITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; RESPIRATORY EPITHELIUM; VIRUS INFECTION; ADAPTATION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHENOTYPE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VIROLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELLULAR MICROENVIRONMENT; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; PHENOTYPE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84940666458     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0030-2015     Document Type: Article

References (45)

1. Guilliams M, De Kleer I, Henri S, et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med 2013; 210: 1977–1992. .
2. Maus UA, Janzen S, Wall G, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 2006; 35: 227–235. .
3. Janssen WJ, Barthel L, Muldrow A, et al. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med 2011; 184: 547–560.
4. Sawyer RT, Strausbauch PH, Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest 1982; 46: 165–170. .
5. Schmidt A, Sucke J, Fuchs-Moll G, et al. Macrophages in experimental rat lung isografts and allografts: infiltration and proliferation in situ. J Leukoc Biol 2007; 81: 186–194. .
6. Tarling JD, Lin HS, Hsu S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol 1987; 42: 443–446. .
7. Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013; 38: 79–91. .
8. McCullers JA, McAuley JL, Browall S, et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010; 202: 1287–1295. .
9. Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014; 14: 81–93. .
10. Zaynagetdinov R, Sherrill TP, Kendall PL, et al. Identification of myeloid cell subsets in murine lungs using flow cytometry. Am J Respir Cell Mol Biol 2013; 49: 180–189. .
11. Misharin AV, Morales-Nebreda L, Mutlu GM, et al. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am J Respir Cell Mol Biol 2013; 49: 503–510. .
12. Fujimori T, Grabiec AM, Kaur M, et al. The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung. Mucosal Immunol 2015 [In press DOI: 10.1038/mi.2014.129]. .
13. Mayer AK, Bartz H, Fey F, et al. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur J Immunol 2008; 38: 1689–1699. .
14. Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013; 191: 1250–1259. .
15. Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008; 205: 323–329. .
16. Williams AE, Edwards L, Humphreys IR, et al. Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol 2004; 173: 7435–7443. .
17. Saeed S, Quintin J, Kerstens HH, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014; 345: 1251086. .
18. Cheng SC, Quintin J, Cramer RA, et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014; 345: 1250684. .
19. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19: 571–582. .
20. Lehtinen P, Jartti T, Virkki R, et al. Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis 2006; 25: 463–469. .
21. Hament JM, Kimpen JL, Fleer A, et al. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999; 26: 189–195. .
22. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186: 341–350. .
23. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962–970. .
24. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006; 6: 303–312. .
25. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362: 1708–1719. .
26. Lucas S. Predictive clinicopathological features derived from systematic autopsy examination of patients who died with A/H1N1 influenza infection in the UK 2009–10 pandemic. Health Technol Assess 2010; 14: 83–114. .
27. Falsey AR, Becker KL, Swinburne AJ, et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 2013; 208: 432–441. .
28. Habibzay M, Weiss G, Hussell T. Bacterial superinfection following lung inflammatory disorders. Future Microbiol 2013; 8: 247–256. .
29. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014; 12: 252–262. .
30. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004; 172: 7603–7609. .
31. Snelgrove RJ, Goulding J, Didierlaurent AM, et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 2008; 9: 1074–1083. .
32. Goulding J, Godlee A, Vekaria S, et al. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J Infect Dis 2011; 204: 1086–1094. .
33. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat Med 2008; 14: 558–564. .
34. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119: 1910–1920. .
35. Habibzay M, Saldana JI, Goulding J, et al. Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol 2012; 5: 524–534. .
36. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008; 8: 327–336. .
37. Linger RM, Keating AK, Earp HS, et al. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 2008; 100: 35–83. .
38. Alciato F, Sainaghi PP, Sola D, et al. TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/ macrophages. J Leukoc Biol 2010; 87: 869–875. .
39. Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol 2010; 22: 740–746. .
40. Sharif MN, Sosic D, Rothlin CV, et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006; 203: 1891–1901. .
41. Ekman C, Linder A, Akesson P, et al. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 2010; 14: R158. .
42. Borgel D, Clauser S, Bornstain C, et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006; 34: 219–222. .
43. Guignant C, Venet F, Planel S, et al. Increased MerTK expression in circulating innate immune cells of patients with septic shock. Intensive Care Med 2013; 39: 1556–1564. .
44. Milner CM, Day AJ. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 2003; 116: 1863–1873.
45. Okroj M, Holmquist E, Sjölander J, et al. Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade. J Biol Chem 2012; 287: 20100–20110. .